EP
DCPH
Eversept Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Hold |
0
| – | – | – | 118 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 114 |
|
2021
Q2 | – | Sell |
-345,717
| Closed | -$15.5M | – | 94 |
|
2021
Q1 | $15.5M | Buy |
345,717
+99,477
| +40% | +$4.46M | 1.17% | 27 |
|
2020
Q4 | $14.1M | Sell |
246,240
-156,193
| -39% | -$8.91M | 1.65% | 20 |
|
2020
Q3 | $20.6M | Sell |
402,433
-16,219
| -4% | -$832K | 4.59% | 9 |
|
2020
Q2 | $25M | Buy |
418,652
+4,571
| +1% | +$273K | 3.43% | 10 |
|
2020
Q1 | $17M | Buy |
414,081
+285,333
| +222% | +$11.7M | 4.24% | 8 |
|
2019
Q4 | $8.01M | Buy |
128,748
+106,748
| +485% | +$6.64M | 1.42% | 18 |
|
2019
Q3 | $747K | Sell |
22,000
-283,233
| -93% | -$9.61M | 0.23% | 46 |
|
2019
Q2 | $6.88M | Buy |
305,233
+54,801
| +22% | +$1.24M | 1.93% | 13 |
|
2019
Q1 | $5.81M | Buy |
250,432
+180,732
| +259% | +$4.19M | 1.7% | 17 |
|
2018
Q4 | $1.46M | Buy |
+69,700
| New | +$1.46M | 0.79% | 24 |
|
2018
Q3 | – | Sell |
-9,536
| Closed | -$375K | – | 73 |
|
2018
Q2 | $375K | Sell |
9,536
-75,554
| -89% | -$2.97M | 0.17% | 62 |
|
2018
Q1 | $1.71M | Buy |
+85,090
| New | +$1.71M | 0.79% | 26 |
|